| 0 (0%) | 04-19 02:41 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 54.09 |
1-year : | 56.11 |
| Resists | First : | 46.31 |
Second : | 48.04 |
| Pivot price | 46.3 |
|||
| Supports | First : | 43.52 |
Second : | 36.2 |
| MAs | MA(5) : | 44.88 |
MA(20) : | 46.4 |
| MA(100) : | 42.34  |
MA(250) : | 35.22 |
|
| MACD | MACD : | -0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 9.5 |
D(3) : | 10.6 |
| RSI | RSI(14): 34 |
|||
| 52-week | High : | 48.52 | Low : | 25.2 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CG ] has closed below the lower bollinger band by 7.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 7.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 45.13 - 45.56 | 45.56 - 45.82 |
| Low: | 42.6 - 43.17 | 43.17 - 43.51 |
| Close: | 43.04 - 43.95 | 43.95 - 44.5 |
Thu, 18 Apr 2024
WCG rink hockey: Don Bosco enter U-14 final - mid-day.com
Thu, 04 Apr 2024
WCG Launches New Application on Its ClinSphere Technology Platform - Contract Pharma
Tue, 05 Mar 2024
WCG introduces Statistical Consulting Solutions to address industry resource challenges - ROI-NJ.com
Mon, 04 Mar 2024
WCG Expands Statistical Consulting Solutions - Contract Pharma
Mon, 12 Feb 2024
WCG ClinSphere™: Revolutionizing Clinical Research Technology - PR Newswire
Wed, 07 Feb 2024
Leonard Green-Backed WCG Clinical Counters Merger Fraud Lawsuit - Bloomberg Law
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 361 (M) |
| Shares Float | 263 (M) |
| Held by Insiders | 32.1 (%) |
| Held by Institutions | 60.1 (%) |
| Shares Short | 15,490 (K) |
| Shares Short P.Month | 17,040 (K) |
| EPS | -1.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.36 |
| Profit Margin | -25.2 % |
| Operating Margin | -108.6 % |
| Return on Assets (ttm) | -2.4 % |
| Return on Equity (ttm) | -7.9 % |
| Qtrly Rev. Growth | 25.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 6.7 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 205 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -26.01 |
| PEG Ratio | 0.8 |
| Price to Book value | 3.03 |
| Price to Sales | 6.51 |
| Price to Cash Flow | 76.94 |
| Dividend | 0.34 |
| Forward Dividend | 0 |
| Dividend Yield | 0.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|